Altered expression of γ-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells

Japanese Journal of Cancer Research

Volumn 88, Issue 2, 1997, Pages 213-217

  Kikuchi, Yoshihiro ^a   Hirata, Junko ^a   Yamamoto, Kenji ^a   Ishii, Kenji ^a   Kita, Tsunekazu ^a   Kudoh, Kazuya ^a   Tode, Takehiko ^a   Nagata, Ichiro ^a   Taniguchi, Ken ^b   Kuwano, Michihiko ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cisplatin resistance; Human ovarian cancer cell; Metallothionein; Topoisomerase; glutamylcysteine synthetase

Indexed keywords

CISPLATIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GAMMA GLUTAMYLCYSTEINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IRINOTECAN; MESSENGER RNA; METALLOTHIONEIN; SYNTHETASE;

ARTICLE; CELL LEVEL; DRUG ACCUMULATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

EID: 0030941961     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00368.x     Document Type: Article

References (23)

1. Timmer-Bosscha, H Mulder, N. H. and de Vries, E. G. E. Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br. J. Cancer, 66, 227-238 (1992).
2. Eastman, A. and Schulte, N. Enhanced DNA repair as a mechanism of resistance to cw-diamminedichloroplatinum (II). Biochemistry, 27, 4730-4734 1988).
3. Chen, G. and Zeller, W. J. In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line. J. Cancer Res. Clin. Oncol 116, 443-447 1990).
4. Sriram, R Ali-Osman, F., Livingston, R Ellis, G Needle, M. N. and Stein, D. Modulation of topoisomerase (Topo) II on the kinetics of formation and repair of cisplatinum (cis-DDP) induced DNA-interstrand cross links (DNA-ISC) in human tumor cells sensitive and resistant toris-DDP. Proc. Am. Assoc. Cancer Res 31, 335 (1990).
5. Waud, W. R Harrison, S. D. J Gilbert, K. S Laster, W. R. J. and Griswold, D. P. J. Antitumor drug crossresistance in vivo in a cisplatin-resistant murine P388 leukemia. Cancer Chemother. Pharmacol 27, 456-463 (1991).
6. Kotoh, S Naito, S., Yokomizo, A Kumazawa, J Asakuno, K Kohno, K. and Kuwano, M. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res 54, 3248-3253 1994).
7. Kikuchi, Y Miyauchi, M., Kizawa, I Oomori, K. and Kato, K. Establishment of a cisplatin-resistant human ovarian cancer cell line. J. Natl. Cancer Inst 77, 1181- 1185 1986).
8. Yoshiya, N. Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs. Acta Obstet. Gynaecol. Jpn 38, 1747-1753 1986) (in Japanese).
9. Hirata, J Kikuchi, Y., Kita, T Imaizumi, E Tode, T Ishii, K Kudoh, K. and Nagata, I. Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum (II) by 12-O-tetradecanoyl-13-acetate and D, L-buthionine-S, R-sulphoximine. Int. J. Cancer, 55, 521-527 (1993).
10. Litterst, C. L Gram, T. E Dedrick, R. L Leroy, A. and Guarino, A. M. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum (II) (NSC1198875) to dogs. Cancer Res 36, 2340-2344 1976).
11. Griffith, O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem 106, 207-212 1980).
12. Chomoczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol- chloroform extraction. Anal. Biochem 162, 156-159 1987).
13. Krain, M. and Richards, R. I. Human metallothionein genes-primary structure of the metallothionein-II gene and related processed gene. Nature, 227, 680-685 (1970).
14. Gipp, J. J Chang, C. and Mulcahy, R. T. Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetase. Biochem. Biophys. Res. Commun 185, 29-35 (1992).
15. Andrews, P A. and Howell, S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells, 2, 35-43 (1990).
16. Scanlon, K. J Kashani-Sabet, M., Miyachi, H Sowers, L. C. and Rossi, J. Molecular basis of cisplatin-resistance in human carcinoma: model systems and patients. Anticancer Res 9, 1301-1312 1989).
17. Kikuchi, Y Iwano, I., Miyauchi, M Kita, T Sugita, M Tenjin, Y. and Nagata, I. Possible mechanisms of resistance to cw-diamminedichloroplatinum (II) of human ovarian cancer cells. Jpn. J. Cancer Res 81, 701-706 (1990).
18. Godwin, A. K Meister, A., O'Dwyer, P. J Huang, C. S Hamilton, T. C. and Anderson, M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA, 89, 3070-3074 1992).
19. Saburi, Y Nakagawa, M., Ono, M Sakai, M Muramatsu, M Kohno, K. and Kuwano, M. Increased expression of glutathione S-transferase gene in crs-diamminedichloroplatinum (Il)-resistant variants of a Chinese hamster ovary cell line. Cancer Res 49, 7020-7025 1989).
20. Kasahara, K Fujiwara, Y., Nishio, K Ohmori, T Sugimoto, Y Komiya, K Matsuda, T. and Saijo, N. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 51, 3237-3242 1991).
21. Schilder, R. J Hall, L., Monks, A Handel, L. M Faranc, A. J Jr Ozols, R. F Fojo, A. T. and Hamilton, T. C. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int. J. Cancer, 45, 416- 422 (1990).
22. Takano, H Kohno, K., Ono, M Uchida, Y. and Kuwano, M. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res 51, 3951-3957 1991).
23. Matsuno, K Kohno, K., Sato, S Uchiumi, T Tanimura, H Yamada, Y. and Kuwano, M. Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells. Cancer Res 53, 1085-1090 1993).